Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
| Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
|---|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 | 0 |
| % | 0 | 0 | 0 | 0 | 0 |
[Dilip Davda] The company is engaged in distribution of pharma formulations and manufacturing of freeze dried and frozen foods. The company posted steady growth in its top and bottom lines, but on a minuscule level. Based on FY25 annualized earnings, the issue appears aggressively priced. Small paid-up equity base post IPO indicates longer gestation for migration. There is no harm in skipping this pricey issue. Read detail review...
Hamps Bio IPO Reviews, analysis and views by popular members. Read Hamps Bio Ltd. IPO reviews by retail investors to find recommended ipo to buy.
| Review By | Apply | May Apply | Neutral | Avoid |
|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 |
| % | 0.00 | 0.00 | 0.00 | 0.00 |
| Member | Review |
|---|---|
| No recommendation found. Be the first to post the recommendation. | |
Note:
RHP